Patel Naimish (CIK 2021679) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-01). Recent activity: Buy CRSP (10,000 shares), Sell CRSP (3,786 shares), Buy CRSP (8,125 shares), Sell CRSP (3,150 shares), Buy CRSP (1,508 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-01 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | Buy | 10,000 | $0 |
| 2026-06-01 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | Sell | 3,786 | $210,577 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | Buy | 8,125 | $0 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | Sell | 3,150 | $152,019 |
| 2026-01-27 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | Buy | 1,508 | $49,704 |
| 2025-05-30 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | Buy | 10,000 | $0 |
| 2025-05-30 | CRISPR Therapeutics AG (CRSP) | Chief Medical Officer | Sell | 3,932 | $141,316 |
Source: SEC Form 4 filings · as of 2026-06-01